Symplast Founder Dr. Kusuma to Present Telehealth Session at the 2019 Florida Plastic Surgery Forum
The Californer/10055719

PALM BEACH, Fla. - Californer -- Symplast, the #1 mobile EHR/PM for plastic surgery and med spas that delivers a HIPAA-secure cloud platform to more than 3,500 aesthetic users across the U.S., is proud to feature our Founder and plastic surgeon Dr. Shashi Kusuma as a presenter at the 2019 Florida Society of Plastic Surgeons Meeting November 13th at the Breakers Resort in Palm Beach. Dr. Kusuma will present "2020: The Year Telehealth Transforms Plastic Surgery" to the society attendees. While virtual consultations have become commonplace in aesthetics, this informative session will reveal a hidden opportunity that plastic surgeons have yet to leverage within telemedicine: the virtual follow-up. Dr. Kusuma is also a practicing plastic surgeon based in Fort Lauderdale, Florida, who currently owns three different practices and serves as the medical director for another med spa.

More on The Californer

• TL Foundation Supports Connect's 2026 Cool Companies to Strengthen San Diego's Innovation Economy
• Equestrian Expert Rominger Receives National Recognition Through the INDEPENDENT PRESS AWARD®!
• Scientology Network Celebrates International Day of Happiness with Global Marathon
• New Platform Helps Gig Workers Avoid Paying Taxes on Income They Never Received
• Comedian Marc Yaffee Headlines Willits High School Sober Grad Fundraiser Show

Symplast will also host a live educational webinar on Wednesday, December 18, 2019 at Noon EST where Dr. Kusuma will present "2020: The Year Telehealth Transforms Plastic Surgery" for any plastic surgeons or aesthetic personnel who would like to learn from it. To register for this free webinar, please click here.

Jointly provided by the American Society for Aesthetic Plastic Surgeons (ASAPS), the Florida Society of Plastic Surgeons (FSPS) has assembled best-in-class faculty experts for this three-day symposium. Symplast will also be exhibiting at the Florida Plastic Surgery Forum, located at Table #9. Plastic surgeons attending this symposium can visit Symplast's exhibitor booth during the show for a hands-on demonstration of how our mobile-first cloud platform reimagines aesthetic workflows and simplifies clinical tasks via automation, A.I. and multimedia.

ASAPS members can also learn more about Symplast being the first ANN Optimized Platform, and the first Cloud Platform, for the ASAPS society's Aesthetic Neural Network (ANN).

More on The Californer

• California: Governor Newsom convenes leaders to confront crisis facing boys and men
• Governor Newsom launches campaign to recruit young men, and all Californians, to serve communities and gain job skills 
• VCCCD Announces Ventura College Presidential Finalists
• Squeegex Expands Window Cleaning and Exterior Services Across 30+ San Diego Neighborhoods
• Long Beach: City Recognizes Tsunami Preparedness Week 2026: Know the Risk. Know the Route.

To learn more information about the Telehealth presentation Dr. Kusuma will be presenting, or to discover more about Symplast, please contact hello@symplast.com or visit Symplast at Table #9 at the Florida Plastic Surgery Forum December 13th – 15th, 2019.


About Symplast
Founded by plastic surgeons in 2013, Symplast is the #1 Mobile EHR/Practice Management platform for plastic surgery and med spas. Symplast delivers a HIPAA secure cloud platform to over 3,500 aesthetic users across the country. Symplast's user-friendly, end-to-end solution optimizes aesthetic practices and medspas from anywhere in the world. Your smartphone is now your smartpractice.
From front desk automation to clinical intelligence, Symplast eliminates inefficiencies with a comprehensive ecosystem that includes: EHR, Practice Management, Virtual Consultations, Patient Engagement, e-Prescription, Online Appt. Requests, Financial Intelligence, POS, Analytics, HIPAA Secure Texting, and more. Symplast is also the first ANN Optimized Platform. Visit https://symplast.com or email hello@symplast.com to learn more.